5 Cancer Vaccines to Watch in 2024

Several cancer vaccine candidates are flying through clinical trials with promising results. Unlike traditional vaccines that aim to prevent a disease from occurring, therapeutic cancer vaccines train the patient’s immune system, enabling T cells to patrol the body for cancer cells and destroy them. Progress in personalized medicine has made it easier and much more affordable to sequence patient genomes, pull out unique cancer signatures and make vaccines encoding these neoantigens.

BioSpace compiled a list of five cancer vaccines in mid- to late-stage development and sought insights from two experienced researchers on their respective merits.